Impact of Predictive Genetic Testing

Impact of Predictive Genetic Testing on Quality of Life and Health-related Behaviour

Sponsors

Lead Sponsor: Robert Bosch Medical Center

Source Robert Bosch Medical Center
Brief Summary

Analysing Impact of preemptive genetic testing on quality of life, physical activity and eating behavior at baseline and 3 months after testing.

Overall Status Completed
Start Date September 1, 2016
Completion Date January 31, 2018
Primary Completion Date January 31, 2018
Study Type Observational
Primary Outcome
Measure Time Frame
Quality of Life assessed by the SF-36 questionnaire [followed by its scale information in the Description] 3 months
Physical activity assessed by the IPAQ questionnaire [followed by its scale information in the Description] 3 months
Eating behavior assessed by the modified LEI questionnaire [followed by its scale information in the Description] 3 months
Secondary Outcome
Measure Time Frame
Satisfaction with check up and genetic testing: Likert scale (1-10) 3 months
Enrollment 241
Condition
Intervention

Intervention Type: Diagnostic Test

Intervention Name: Routine check up including genetic testing

Description: Intervention is a routine check up including preemptive genetic testing

Eligibility

Sampling Method: Probability Sample

Criteria:

Inclusion Criteria:

- Age ≥18 years

- informed consent for genetic testing

- informed consent for study participation

Exclusion Criteria:

- Age <18 years

- renal replacement dependency

- pregnancy

- active cancer disease

- no informed consent for genetic testing or study participation

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: Accepts Healthy Volunteers

Verification Date

June 2019

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Robert Bosch Medical Center

Investigator Full Name: Prof. Dr. med. Mark Dominik Alscher

Investigator Title: Medical Director, Managing Director

Has Expanded Access No
Patient Data Undecided
Study Design Info

Observational Model: Cohort

Time Perspective: Prospective

Source: ClinicalTrials.gov